Nuvalent Initiates Phase 3 ALKAZAR Trial of Neladalkib in NSCLC
Neladalkib enters phase 3 trials, targeting advanced ALK-positive NSCLC, promising improved outcomes for TKI-naïve patients with brain metastases.
Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season
Lessons From the Past Season Could Strengthen Prevention and Drive Vaccinations for 2025-2026
AACP 2025: From Research to Action on Representation Gaps in Pharmacy Education
Omolola (Lola) Adeoye-Olatunde, PharmD, MS, discusses findings from a multi-year analysis of American Association of Colleges of Pharmacy (AACP) institutional…
1045: Think Cefepime Has a Mortality Benefit Over Pip-Taz? Not So Fast Say These Authors…
Show notes at pharmacyjoe.com/episode1045. In this episode, I’ll discuss possible design flaws in a recent study that suggested cefepime has…
Influenza Vaccination: Direct and Indirect Impact
Influenza vaccination significantly reduces cases and enhances community immunity, highlighting pharmacists’ vital role in promoting public health.
Hypertension: A Silent Killer Requiring Novel Therapies
Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.
Pharmacist-Led Interventions Significantly Increase Pneumococcal Vaccine Uptake in Older Adults
Education initiatives, facilitation, and immunization on the part of pharmacists were found to significantly increase uptake of pneumococcal vaccines among…
FDA Issues Complete Response Letter for Glofit-GemOx in R/R DLBCL
The CRL states that the STARGLO data do not provide sufficient evidence to support the second-line indication in the US…
Study Investigates Long-Term Cardiometabolic Impact of Early-Onset Obesity
Long-term obesity accelerates aging in young adults, increasing risks for cardiovascular diseases and metabolic dysfunction.